DM-CHOC-PEN Plus Radiation for Brain Tumors
NCT03371004
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
19
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Cancer
Interventions
DRUG:
4-Demethyl-4-cholesteryloxycarbonylpenclomedine
Sponsor
DEKK-TEC, Inc.
Collaborators
[object Object]